ArticleJournal of policy modeling
COVID-19 vaccine rollout-scale and speed carry different implications for corruption.
Article in Journal of policy modeling. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 47 citations in OpenAlex.
- Corruption risks in COVID-19 vaccine deployment: lessons learned for future pandemic preparedness.Globalization and health · 2025Article
- A qualitative examination of the distribution strategies, access, and equitable uptake of the COVID-19 vaccines in Kenya: lessons for the next pandemic.Frontiers in public health · 2025Article
- Scrutinizing the COVID-19 vaccine safety debate.Human vaccines & immunotherapeutics · 2024Article
- Determinants of COVID-19 vaccination coverage in European and Organisation for Economic Co-operation and Development (OECD) countries.Frontiers in public health · 2024Article
- Global Inequities in COVID-19 Vaccination: Associated Factors and Tools to Measure Inequality.Vaccines · 2023Article
- COVID-19 vaccination and governance in the case of low, middle and high-income countries.BMC public health · 2023Article
- Segmentation analysis of the unvaccinated US adult population 2 years into the COVID-19 pandemic, 1 December 2021 to 7 February 2022.Family medicine and community health · 2023Article
- Covid-19 vaccine dissemination: A public health ethical evaluation of Pennsylvania's plan during Phase 1A.Ethics, medicine, and public health · 2022Article
- Understanding the policy dynamics of COVID-19 vaccination in Ghana through the lens of a policy analytical framework.Health research policy and systems · 2022Review
- Managing the risk of COVID-19 via vaccine passports: Modeling economic and policy implications.Managerial and decision economics : MDE · 2022Article
- Predicting COVID-19 vaccine hesitancy in Hong Kong: Vaccine knowledge, risks from coronavirus, and risks and benefits of vaccination.Vaccine: X · 2022Article
- Monitoring User Opinions and Side Effects on COVID-19 Vaccines in the Twittersphere: Infodemiology Study of Tweets.Journal of medical Internet research · 2022Article
- Corruption should be taken into account when considering COVID-19 vaccine allocation.Proceedings of the National Academy of Sciences of the United States of America · 2022Article
- Death takes no bribes: Impact of perceived corruption on the effectiveness of non-pharmaceutical interventions at combating COVID-19.Social science & medicine (1982) · 2022Article
- From the COVID-19 pandemic to corrupt practices: a tale of two evils.Environmental science and pollution research international · 2022Article
- Do disease epidemics force economic activity underground? International evidence.Contemporary economic policy · 2022Article
- Does public health policy quality foster state innovation capacity? Evidence from a global panel data.Frontiers in public health · 2022Article
- Effect of public corruption on the COVID-19 immunization progress.Scientific reports · 2021Article
- Blockchain for COVID-19: a comprehensive review.Personal and ubiquitous computing · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The sanctioning of different coronavirus vaccines (with some approved by regulators for public delivery, and others in the pipeline) has met with relief by many sections of the public and the government. However, partly due to the damages associated with the pandemic and the ensuing euphoria over vaccines' arrival, some of the challenges are mostly being ignored or are not recognized. This paper identifies some pitfalls and drawbacks in vaccine delivery. We argue that the somewhat unique tension between the speed of vaccine delivery and its scale can create opportunities for corrupt behavior that are often at odds with effective means to check abuse. While data on instances of abuse will emerge over time, it is useful to point out different avenues of abuse so that some preventive government actions can be undertaken. Specifically, we argue that the potential for out of turn delivery of vaccines and the stockpiling by unauthorized agents creates incentives for corruption, with the public or bureaucrats initiating corrupt transactions. An understanding of the potential avenues for corruption should guide the formulation of appropriate corruption-control policies and similar challenges that will be faced by policy makers in addressing future pandemics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.